Read + Share
Amedeo Smart
Independent Medical Education
Powell K, Burns MC, Prasad V. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. Eur Urol 2023;83:101-102.PMID: 36153246
Email
LinkedIn
Facebook
Twitter
Privacy Policy